CTLA4 and arthritic joint disease: Our analyses reveal that Th1-CD8+ T cells play a pivotal role in arthritis-irAE disease pathogenesis, and Th17 cells and transient Th17 cells, enriched in arthritis after combined CTLA-4 and PD-1 inhibitor therapy, are involved in steroid resistance.